TOP NEWS

Metro

World

Spiritual

16 Mar 2020

Clinical Trials For New Drug To Treat Coronavirus Begins

French pharmaceutical giant Sanofi and American drugmaker Regeneron said on Monday they have started clinical trials for a new drug in patients hospitalised with severe coronavirus infections.
In a statement, they said phase 2 and 3 trials were underway for Kevzara, an immunosuppressor.

Regeneron will trial in the United States, while Sanofi plans trials initially in Italy, particularly hard hit by the novel coronavirus pandemic.

Kevzara, the brand name for sarilumab, an antibody that blocks the ability of some viruses to latch on to humane immune cells, has been in development since 2017.

Specifically, it inhibits the immune receptor that plays a key role in lung inflammation, something severe coronavirus patients suffer from.

Around 400 patients will take part in the studies, which will evaluate the effect of Kevzara on fever and oxygenation levels of patients.

It will also look at how the drug works over the long term in reducing mortality rates, and potentially how it can reduce the need for respiratory apparatus in hospital.

The number of novel coronavirus cases globally stood at 168,250 with 6,501 deaths, across 142 countries and territories at 0900 GMT Monday, according to an AFP tally based on official sources.

(AFP)

SHARE THIS NEWS USING ANY OF THE BUTTON BELOW

PLACE YOUR TEXT ADVERT BELOW ⬇⬇⬇

SHARE YOUR STORY WITH US VIA EMAIL: Site Manager: tunbinext@gmail.com

CLICK HERE TO JOIN OUR FACEBOOK FAN PAGE FOR INSTANT NEWS UPDATE

CLICK HERE TO JOIN US ON OUR YOUTUBE CHANNEL FOR NEWS UPDATE

CLICK HERE TO JOIN US ON TWITTER FOR INSTANT NEWS UPDATE: @247NNU

CLICK HERE TO JOIN US ON QUORA

CLICK HERE FOR INSTANT UPDATES ON INSTAGRAM

Post a comment

 
Copyright © 2015 247 Nigeria News Update
Website by Tech Guardian